GB0406389D0 - Recombinant herpes simplex virus and uses therefor - Google Patents
Recombinant herpes simplex virus and uses thereforInfo
- Publication number
- GB0406389D0 GB0406389D0 GBGB0406389.7A GB0406389A GB0406389D0 GB 0406389 D0 GB0406389 D0 GB 0406389D0 GB 0406389 A GB0406389 A GB 0406389A GB 0406389 D0 GB0406389 D0 GB 0406389D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- herpes simplex
- simplex virus
- recombinant herpes
- uses therefor
- therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0406389.7A GB0406389D0 (en) | 2004-03-22 | 2004-03-22 | Recombinant herpes simplex virus and uses therefor |
PCT/EP2005/003639 WO2005092374A2 (en) | 2004-03-22 | 2005-03-22 | Recombinant herpes simplex virus and uses therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0406389.7A GB0406389D0 (en) | 2004-03-22 | 2004-03-22 | Recombinant herpes simplex virus and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0406389D0 true GB0406389D0 (en) | 2004-04-21 |
Family
ID=32118151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0406389.7A Ceased GB0406389D0 (en) | 2004-03-22 | 2004-03-22 | Recombinant herpes simplex virus and uses therefor |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0406389D0 (en) |
WO (1) | WO2005092374A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2317749B1 (en) * | 2006-07-20 | 2010-02-19 | Consejo Superior Investig. Cientificas | USE OF A PROTEIC COMPOUND DERIVED FROM GLYCROPROTEIN (GG) OF HSV FOR THE PREPARATION OF A USEFUL PHARMACEUTICAL COMPOSITION FOR INDUCTION OF CELLULAR MIGRATION MEDIATED BY CHEMIOQUINS. |
WO2009120339A2 (en) * | 2008-03-24 | 2009-10-01 | President And Fellows Of Harvard College | Vectors for delivering disease neutralizing agents |
JP5723280B2 (en) * | 2008-10-03 | 2015-05-27 | ノヴァルティス アーゲーNovartis Ag | Bovine herpesvirus type 1 compositions, vaccines and methods |
GB201301119D0 (en) * | 2013-01-22 | 2013-03-06 | Vaxxit Srl | Viral vaccines |
US10010594B2 (en) | 2014-02-11 | 2018-07-03 | University Of Miami | Methods and compositions for transgene expression in a herpesvirus vector system |
AU2017212713B2 (en) | 2016-01-27 | 2023-01-19 | Oncorus, Inc. | Oncolytic viral vectors and uses thereof |
CN117143837A (en) * | 2016-03-25 | 2023-12-01 | 普瑞菲根公司 | High transduction HSV vector |
CN109310728B (en) * | 2016-03-25 | 2022-08-12 | 普瑞菲根公司 | HSV vectors for delivery of NT3 and treatment of CIPN |
SG11202000691XA (en) | 2017-07-26 | 2020-02-27 | Oncorus Inc | Oncolytic viral vectors and uses thereof |
CN112656798B (en) * | 2020-12-28 | 2023-03-07 | 复旦大学附属肿瘤医院 | Application of CDK7 targeted inhibitor in preparation of medicine for treating cytokine release syndrome |
EP4314028A1 (en) * | 2021-04-02 | 2024-02-07 | Krystal Biotech, Inc. | Viral vectors for cancer therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6040169A (en) * | 1991-01-31 | 2000-03-21 | Medical Research Council | Herpes simplex virus-1 deletion variants and vaccines thereof |
GB9415319D0 (en) * | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
-
2004
- 2004-03-22 GB GBGB0406389.7A patent/GB0406389D0/en not_active Ceased
-
2005
- 2005-03-22 WO PCT/EP2005/003639 patent/WO2005092374A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005092374A3 (en) | 2005-12-08 |
WO2005092374A2 (en) | 2005-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1673460T1 (en) | Recombinant vaccines and use thereof | |
EP1824796A4 (en) | Protein scaffolds and uses thereof | |
PL372937A1 (en) | Viral antigens | |
EP1804831A4 (en) | Listeria-based and llo-based vaccines | |
GB0206359D0 (en) | Viral antigens | |
ZA200705060B (en) | Recombinant Newcastle disease virus | |
EP1829959A4 (en) | Recombinant microorganism | |
IL199528A0 (en) | Recombinant lubricin molecules and uses thereof | |
ZA200703313B (en) | Recombinant human T2 RNase and uses thereof | |
EP1723247A4 (en) | Recombinant perforin, expression and uses thereof | |
IL179497A0 (en) | Carboranylporphyrins and uses thereof | |
GB0406389D0 (en) | Recombinant herpes simplex virus and uses therefor | |
IL180365A0 (en) | Carboranylporphyrins and uses thereof | |
EP1731599A4 (en) | Method of constructing recombinant herpes simplex virus | |
GB0416487D0 (en) | Modified virus | |
AU2003274915A8 (en) | Recombinant double-stranded rna phages and uses thereof | |
EP1705182A4 (en) | Antitumoral and antiviral peptides | |
EP1829969A4 (en) | Novel polypeptide and the use thereof | |
EP1842857A4 (en) | Mutant interferon proteins and use thereof | |
GB0405657D0 (en) | Recombinant herpes simplex virus and uses therefor | |
EP1833989A4 (en) | Virus preparations and methods | |
GB0409596D0 (en) | Novel herpes simplex viruses and uses thereof | |
GB0408103D0 (en) | Novel herpes simplex viruses | |
AUPS037002A0 (en) | Viral variants and uses therefor | |
GB0517617D0 (en) | Treatment using herpes simplex virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |